KMT2A and leukemia: To validate our initial observation, we cloned the two sgRNAs against Wnk1 giving the strongest dropout in the screen and transduced them individually in the Cas9-expressing MLL-AF9 driven mouse leukaemia cells (hereinafter referred to as MA9 leukaemia cells) (Fig. 1a).